GlassScriptPhysician profile
Adam D Goldkind
NPI 1902069412
$5,652.36
in general payments reported to CMS, 2019-2025
35 companies · $1,127 in 2025
The $1,127 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $400 · 2021: $560 · 2022: $943 · 2023: $1,101 · 2024: $768 · 2025: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,996.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,111.76 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Organogenesis INC. | $1,051.36 | 2019-2025 | Puraply, Affinity, Puraply Wound Matrix |
| Kci USA, INC. | $238.62 | 2019 | |
| Inari Medical, INC. | $200.00 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $177.03 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Surgenex LLC | $157.34 | 2025 | Surmatrix, Pellograft, Surgraft |
| Next Science LLC | $137.33 | 2023 | Blastx, Xperience, Surgx |
| Osiris Therapeutics INC. | $130.75 | 2019 | |
| Paragon 28, INC. | $116.45 | 2022-2025 | Bun-Yo-Matic, Portfolio, Phantom Metatarsal Shortening |
| Treace Medical Concepts, INC. | $100.58 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $97.23 | 2020-2023 | Allograft |
| Integra Lifesciences Corporation | $83.09 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $76.41 | 2024-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $74.56 | 2022-2023 | Orbactiv, Kimyrsa |
| Stryker Corporation | $73.83 | 2023-2025 | Augment Injectable, Ortholoc 2 Lapifuse |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $67.65 | 2024-2025 | |
| Depuy Synthes Sales INC. | $67.37 | 2023-2024 | Motoband |
| Abbott Laboratories | $65.38 | 2019-2024 | Proclaim |
| Misonix INC | $61.16 | 2019-2021 | |
| Horizon Therapeutics Plc | $57.37 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.57 | 2020-2023 | Jublia |
| Aroa Biosurgery Incorporated | $47.34 | 2022-2024 | |
| Solventum Corporation | $43.86 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, Prevena |
| Tactile Systems Technology INC | $43.09 | 2019-2022 | |
| Bioventus LLC | $42.04 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Osteomed LLC | $41.01 | 2021 | |
| Sebela Pharmaceuticals INC. | $36.72 | 2020-2021 | |
| Ets Wound Care LLC | $35.31 | 2023 | |
| Acera Surgical, INC. | $34.56 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $30.88 | 2025 | |
| Nevro Corp. | $26.96 | 2023 | Senza |
| Mimedx Group, INC. | $19.68 | 2024 | |
| Sanara Medtech INC. | $18.36 | 2024 | Celleraterx |
| Kowa Pharmaceuticals America, INC. | $16.76 | 2023 | Seglentis |
| Wright Medical Technology, INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Goldkind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.